Table 3.
Assessment of BDA volume, rostro-caudal diffusion and analyzed gray matter area of the spinal cord
| BDA Injection |
Gray Matter Area (mm2) |
|||
|---|---|---|---|---|
| Volume (mm3) | Diffusion (mm) | Lumbosacral | Thoracic | |
| Acute BDA injection | ||||
| T4-transection | 0.11 ± 0.04 | 0.60 ± 0.12 | 18.89 ± 4.52 | 18.81 ± 3.04 |
| Sham | 0.11 ± 0.02 | 0.64 ± 0.10 | 19.21 ± 4.16 | 17.29 ± 3.97 |
| Delayed BDA injection | ||||
| T4-transection | 0.29 ± 0.06 | 1.32 ± 0.24 | 22.83 ± 3.58 | 15.99 ± 1.51 |
| Sham | 0.29 ± 0.11 | 1.27 ± 0.30 | 23.87 ± 1.83 | 16.62 ± 2.66 |
Data expressed as mean ± SD